We are live on ! Find out more
SGYP

Synergy Pharmaceuticals, Inc Common Stock
SGYP

Delisted

SGYP was delisted on the 7th of March, 2019.

Back to rankings

12 hedge funds and large institutions have $1K invested in Synergy Pharmaceuticals, Inc Common Stock in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

87% less funds holding

Funds holding: 89 → 12 (-77)

97% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 79

100% less capital invested

Capital invested by funds: $4.12M → $1K (-$4.12M)

Holders
12
Holders Change
-77
Holders Change %
-86.52%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
79
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$23.7K
2
WS
Wedbush Securities
California
+$8.3K
3
BWA
BDO Wealth Advisors
Florida
+$1.02K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.38M
2
State Street
State Street
Massachusetts
-$495K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$361K
4
Northern Trust
Northern Trust
Illinois
-$281K
5
JG
Jefferies Group
New York
-$195K
Name Holding Trade Value Shares
Change 		Change in
Stake
HF
51
HRT Financial
New York
– -$3K -27,382 Closed
BA
52
Ballew Advisors
Mississippi
– -$8K -26,200 Closed
Barclays
53
Barclays
United Kingdom
– -$3K -25,084 Closed
Commonwealth Equity Services
54
Commonwealth Equity Services
Massachusetts
– -$2K -25,069 Closed
LBD
55
Landsberg Bennett & Dubbaneh
Florida
– -$3K -24,680 Closed
Janney Montgomery Scott
56
Janney Montgomery Scott
Pennsylvania
– -$3K -24,000 Closed
Jane Street
57
Jane Street
New York
– -$2K -21,083 Closed
JMPWA
58
JP Morgan Private Wealth Advisors
California
– -$2K -20,000 Closed
WP
59
WMS Partners
Maryland
– -$2K -20,000 Closed
AIP
60
Ameritas Investment Partners
Nebraska
– -$2K -19,906 Closed
Creative Planning
61
Creative Planning
Kansas
– -$2K -18,983 Closed
RCAG
62
Rehmann Capital Advisory Group
Michigan
– -$2.14K -18,774 Closed
Prudential Financial
63
Prudential Financial
New Jersey
– -$2K -18,340 Closed
D.E. Shaw & Co
64
D.E. Shaw & Co
New York
– -$2K -13,359 Closed
Royal Bank of Canada
65
Royal Bank of Canada
Ontario, Canada
– -$1K -12,678 Closed
PAG
66
Private Advisor Group
New Jersey
– -$1K -12,400 Closed
Simplex Trading
67
Simplex Trading
Illinois
– -$1K -11,967 Closed
SSB
68
Sandy Spring Bank
Maryland
– -$1K -7,650 Closed
BNP Paribas Financial Markets
69
BNP Paribas Financial Markets
France
– -$838 -7,361 Closed
Credit Agricole
70
Credit Agricole
France
– -$1K -6,000 Closed
FANJ
71
Financial Architects (New Jersey)
New Jersey
– -$1K -5,000 Closed
APA
72
American Portfolios Advisors
New York
– -$410 -3,600 Closed
FDCDDQ
73
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$276 -2,425 Closed
IA
74
IFP Advisors
Florida
– -$509 -2,000 -33%
CG
75
Cutler Group
California
– -$76 -300 -3%
1 2
3
4

SGYP Hedge Fund Activity: Q1 2019 in Review

12 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) for Q1 2019, worth a combined $1K — down 100% from $4.12M a quarter earlier.

Sellers outnumbered buyers: 79 funds closed out of SGYP and 2 opened new positions — a net loss of 77 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $23.7K. The largest seller was BlackRock, exiting entirely with an estimated $1.38M sold.

  • 12 institutional investors held Synergy Pharmaceuticals, Inc Common Stock (SGYP) as of Q1 2019, down from 89 in Q4 2018.
  • Funds reported $1K of Synergy Pharmaceuticals, Inc Common Stock stock for Q1 2019, down 100% quarter-over-quarter.
  • 2 funds opened new Synergy Pharmaceuticals, Inc Common Stock positions in Q1 2019 and 79 closed out, a net change of -77 holders.
  • The largest Synergy Pharmaceuticals, Inc Common Stock buyer in Q1 2019 was Tower Research Capital (TRC), an estimated $23.7K added.
  • The largest Synergy Pharmaceuticals, Inc Common Stock seller in Q1 2019 was BlackRock, an estimated $1.38M sold.

Based on aggregated 13F filings for Q1 2019.